One of Wall Street's most prominent billionaire money managers has been a persistent seller of the face of the artificial ...
Historically, top-performing companies continue to generate robust returns. Businesses that conduct stock splits generate ...
Krispy Kreme's global brand provides a cushion, but execution will ultimately determine whether it becomes a long-term success. This is a high-risk, but potentially high-reward turnaround story.
Total production -- Reached a quarterly record of approximately 1.62 million BOEs per day, reflecting a 19% increase, or ...
Quantum Computing Investors Need to Wake Up! IonQ's $2.5 Billion Warning Can't Be Ignored Any Longer. So far, these ...
One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.
Earlier this year, Bill Ackman's fund took a large stake in a company that it views as a free cash flow machine with ...
If you are looking to expand your investments in AI but want to diversify your portfolio away from chip stocks, I think one ...
MPM BioImpact fully exited its position in Crinetics Pharmaceuticals during the third quarter, a move disclosed in the fund’s ...
Walmart's results showcase the nuances of purchasing decisions. Often, consumers don't eliminate a purchase, but shift the ...
Schulman has wasted little time in making a big shakeup, with the company recently announcing that it will be laying off ...
Exclusive Supply Agreement: A contractual arrangement where UFP Technologies ( UFPT 2.21%) is the sole supplier of specified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results